Intravenous infusion ascitic fluid during hemodialysis: a study of 108 treatments in 13 uremic cases.
Nephrogenic ascites is a clinical diagnosis defined as persistent ascites in an uremic patient without evidence for a causative underlying disease. It imperils the patient's life with intradialytic hypotension, however there is no effective therapy other than renal transplantation so far. In 13 cases, 108 treatments with i.v. ascites infusion were performed with hemofilter alone or combined with plasmafilter during hemodialysis over past 7-years. The ascitic fluid was filtrated and dialyzed before it was intravenously infused into the blood compartment of the hemofilter. There were a mean of 8.38 treatments per patient in a period of 56 days and 3,275.9 +/- 1,359.5 ml of ascitic fluid were removed per treatment. The patients' appetite and physical ability were considerably improved and the intradialytic hypotensions disappeared immediately following the initiation of ascitic fluid infusions. In this study, one patient was transplanted successfully. The longest interval without ascitic fluid infusion was 127 days. Main side effect was light pyrogenic reaction, which was presented in 12.96% of the total treatments. It is concluded that this method permits to continue hemodialysis, improves the nutritional condition and prolongs the lifespan by conserving and reusing the ascites protein.
Liu
J
J
Department of Nephrology, Airforce Main Hospital, Beijing, PR of China.
Zhang
C
C
Zhu
X
X
Shang
S
S
Li
W
W
Gu
Q
Q
D000328:Adult; D000368:Aged; D001202:Ascitic Fluid / Q000628:therapy*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects*; D012189:Retrospective Studies; D014511:Uremia / Q000628:therapy*
D011506:Proteins